Investigating genetic drivers of dermatomyositis pathogenesis using meta-analysis

Aims: Dermatomyositis (DM) is a progressive, idiopathic inflammatory myopathy with poorly understood pathogenesis. A hallmark of DM is an increased risk for developing breast, ovarian, and lung cancer. Since autoantibodies against anti-TIF-1-γ, a member of the tripartite motif (TRIM) proteins, has a...

Full description

Bibliographic Details
Main Authors: Jihad Aljabban, Saad Syed, Sharjeel Syed, Michael Rohr, Noah Weisleder, Kevin E. McElhanon, Laith Hasan, Laraib Safeer, Kalyn Hoffman, Nabeal Aljabban, Mohamed Mukhtar, Nikhil Adapa, Zahir Allarakhia, Maryam Panahiazar, Isaac Neuhaus, Susan Kim, Dexter Hadley, Wael Jarjour
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844020317096
_version_ 1819003673780420608
author Jihad Aljabban
Saad Syed
Sharjeel Syed
Michael Rohr
Noah Weisleder
Kevin E. McElhanon
Laith Hasan
Laraib Safeer
Kalyn Hoffman
Nabeal Aljabban
Mohamed Mukhtar
Nikhil Adapa
Zahir Allarakhia
Maryam Panahiazar
Isaac Neuhaus
Susan Kim
Dexter Hadley
Wael Jarjour
author_facet Jihad Aljabban
Saad Syed
Sharjeel Syed
Michael Rohr
Noah Weisleder
Kevin E. McElhanon
Laith Hasan
Laraib Safeer
Kalyn Hoffman
Nabeal Aljabban
Mohamed Mukhtar
Nikhil Adapa
Zahir Allarakhia
Maryam Panahiazar
Isaac Neuhaus
Susan Kim
Dexter Hadley
Wael Jarjour
author_sort Jihad Aljabban
collection DOAJ
description Aims: Dermatomyositis (DM) is a progressive, idiopathic inflammatory myopathy with poorly understood pathogenesis. A hallmark of DM is an increased risk for developing breast, ovarian, and lung cancer. Since autoantibodies against anti-TIF-1-γ, a member of the tripartite motif (TRIM) proteins, has a strong association with malignancy, we examined expression of the TRIM gene family to identify pathways that may be contributing to DM pathogenesis. Materials and methods: We employed the Search Tag Analyze Resource for GEO platform to search the NCBI Gene Expression Omnibus to elucidate TRIM family gene expression as well as oncogenic drivers in DM pathology. We conducted meta-analysis of the data from human skin (60 DM vs 34 healthy) and muscle (71 DM vs 22 healthy). Key findings: We identified genes involved in innate immunity, antigen presentation, metabolism, and other cellular processes as facilitators of DM disease activity and confirmed previous observations regarding the presence of a robust interferon signature. Moreover, analysis of DM muscle samples revealed upregulation of TRIM14, TRIM22, TRIM25, TRIM27, and TRIM38. Likewise, analysis of DM skin samples showed upregulation of TRIM5, TRIM6, TRIM 14, TRIM21, TRIM34, and TRIM38 and downregulation of TRIM73. Additionally, we noted upregulation of oncogenes IGLC1, IFI44, POSTN, MYC, NPM1, and IDO1 and related this change to interferon signaling. While the clinical data associated with genetic data that was analyzed did not contain clinical data regarding malignancy in these cohorts, the observed genetic changes may be associated with homeostatic and signaling changes that relate to the increased risk in malignancy in DM. Significance: Our results implicate previously unknown genes as potential drivers of DM pathology and suggest certain TRIM family members may have disease-specific roles with potential diagnostic and therapeutic implications.
first_indexed 2024-12-20T23:24:45Z
format Article
id doaj.art-69b214ceceef4e5489ce1d16e32be58e
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-12-20T23:24:45Z
publishDate 2020-09-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-69b214ceceef4e5489ce1d16e32be58e2022-12-21T19:23:25ZengElsevierHeliyon2405-84402020-09-0169e04866Investigating genetic drivers of dermatomyositis pathogenesis using meta-analysisJihad Aljabban0Saad Syed1Sharjeel Syed2Michael Rohr3Noah Weisleder4Kevin E. McElhanon5Laith Hasan6Laraib Safeer7Kalyn Hoffman8Nabeal Aljabban9Mohamed Mukhtar10Nikhil Adapa11Zahir Allarakhia12Maryam Panahiazar13Isaac Neuhaus14Susan Kim15Dexter Hadley16Wael Jarjour17University of Wisconsin Hospital and Clinics, Madison, WI, USAStanford University School of Medicine, Palo Alto, CA, USAUniversity of Chicago Medical Center, Chicago, IL, USAUniversity of Central Florida College of Medicine, Orlando, FL, USAThe Ohio State University College of Medicine, Columbus, OH, USAThe Ohio State University College of Medicine, Columbus, OH, USATulane School of Medicine, New Orleans, LA, USABaylor College of Medicine, Houston, TX, USAThe Ohio State University College of Medicine, Columbus, OH, USAPennsylvannia State College of Medicine, Hershey, PA, USAMichigan State University College of Human Medicine, Lansing, MI, USASUNY Upstate Medical Center, Syracuse, NY, USAThe Ohio State University College of Medicine, Columbus, OH, USAUniversity of California San Francisco, San Francisco, CA, USAUniversity of California San Francisco, San Francisco, CA, USAUniversity of California San Francisco, San Francisco, CA, USAUniversity of Central Florida College of Medicine, Orlando, FL, USAThe Ohio State University College of Medicine, Columbus, OH, USA; Corresponding author.Aims: Dermatomyositis (DM) is a progressive, idiopathic inflammatory myopathy with poorly understood pathogenesis. A hallmark of DM is an increased risk for developing breast, ovarian, and lung cancer. Since autoantibodies against anti-TIF-1-γ, a member of the tripartite motif (TRIM) proteins, has a strong association with malignancy, we examined expression of the TRIM gene family to identify pathways that may be contributing to DM pathogenesis. Materials and methods: We employed the Search Tag Analyze Resource for GEO platform to search the NCBI Gene Expression Omnibus to elucidate TRIM family gene expression as well as oncogenic drivers in DM pathology. We conducted meta-analysis of the data from human skin (60 DM vs 34 healthy) and muscle (71 DM vs 22 healthy). Key findings: We identified genes involved in innate immunity, antigen presentation, metabolism, and other cellular processes as facilitators of DM disease activity and confirmed previous observations regarding the presence of a robust interferon signature. Moreover, analysis of DM muscle samples revealed upregulation of TRIM14, TRIM22, TRIM25, TRIM27, and TRIM38. Likewise, analysis of DM skin samples showed upregulation of TRIM5, TRIM6, TRIM 14, TRIM21, TRIM34, and TRIM38 and downregulation of TRIM73. Additionally, we noted upregulation of oncogenes IGLC1, IFI44, POSTN, MYC, NPM1, and IDO1 and related this change to interferon signaling. While the clinical data associated with genetic data that was analyzed did not contain clinical data regarding malignancy in these cohorts, the observed genetic changes may be associated with homeostatic and signaling changes that relate to the increased risk in malignancy in DM. Significance: Our results implicate previously unknown genes as potential drivers of DM pathology and suggest certain TRIM family members may have disease-specific roles with potential diagnostic and therapeutic implications.http://www.sciencedirect.com/science/article/pii/S2405844020317096BioinformaticsGeneticsImmunologyMolecular biologyPathologyDermatomyositis
spellingShingle Jihad Aljabban
Saad Syed
Sharjeel Syed
Michael Rohr
Noah Weisleder
Kevin E. McElhanon
Laith Hasan
Laraib Safeer
Kalyn Hoffman
Nabeal Aljabban
Mohamed Mukhtar
Nikhil Adapa
Zahir Allarakhia
Maryam Panahiazar
Isaac Neuhaus
Susan Kim
Dexter Hadley
Wael Jarjour
Investigating genetic drivers of dermatomyositis pathogenesis using meta-analysis
Heliyon
Bioinformatics
Genetics
Immunology
Molecular biology
Pathology
Dermatomyositis
title Investigating genetic drivers of dermatomyositis pathogenesis using meta-analysis
title_full Investigating genetic drivers of dermatomyositis pathogenesis using meta-analysis
title_fullStr Investigating genetic drivers of dermatomyositis pathogenesis using meta-analysis
title_full_unstemmed Investigating genetic drivers of dermatomyositis pathogenesis using meta-analysis
title_short Investigating genetic drivers of dermatomyositis pathogenesis using meta-analysis
title_sort investigating genetic drivers of dermatomyositis pathogenesis using meta analysis
topic Bioinformatics
Genetics
Immunology
Molecular biology
Pathology
Dermatomyositis
url http://www.sciencedirect.com/science/article/pii/S2405844020317096
work_keys_str_mv AT jihadaljabban investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT saadsyed investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT sharjeelsyed investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT michaelrohr investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT noahweisleder investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT kevinemcelhanon investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT laithhasan investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT laraibsafeer investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT kalynhoffman investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT nabealaljabban investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT mohamedmukhtar investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT nikhiladapa investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT zahirallarakhia investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT maryampanahiazar investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT isaacneuhaus investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT susankim investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT dexterhadley investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis
AT waeljarjour investigatinggeneticdriversofdermatomyositispathogenesisusingmetaanalysis